Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-174

  1. 3,794 Posts.
    lightbulb Created with Sketch. 2651
    New Head of CBER commenting on our director back in 2022.
    https://www.drvinayprasad.com/p/duty?utm_source=publication-search

    I was one of the first to point out that myocarditis was a clear and concerning safety signal in adolescents. I continue to believe that Moderna should be prohibited by the US FDA for people under the age of 40. Recently, a private health system contacted me saying that they had made that decision internally.

    Because I wrote so many op-eds on this issue, I was called anti-vaxxer by people who are not very smart, and just as irrational as anti-vaxxers but just in the anti-anti-vax direction. As a doctor who is personally supervised many vaccines in the post autologous stem cell transplant setting, I found this characterization bizarre. But, I couldn't focus on it because duty.

    When the FDA rammed through boosting all people, against the advice of Marion Gruber and Philip Krause, the two FDA officials who resigned, I analyzed the data myself. I quickly came to the conclusion the data was lacking— just like Paul Offit did. And again I pushed on this issue, which also earned me great professional scorn & punishment. But mostly from people who couldn't understand the issues at stake.


    Tell me that Mesoblast will be delayed in getting FDA access?

    RFK pro cells
    Makary pro Krause
    Prasad pro Krause



    Reg

 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$1.86
Change
0.065(3.62%)
Mkt cap ! $2.376B
Open High Low Value Volume
$1.83 $1.89 $1.83 $8.165M 4.404M

Buyers (Bids)

No. Vol. Price($)
2 6744 $1.86
 

Sellers (Offers)

Price($) Vol. No.
$1.86 5904 3
View Market Depth
Last trade - 16.10pm 16/06/2025 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.